LClose 2.17 Price 2.17
Change 0.00 (0.00%) Low 2.17
High 2.17 EPS 0.09
PE 20.22 Shares Outs. 1,725,234,886
52WkHigh 2.85 52WkLow 1.90
50d Mov Avg 2.11 200d Mov Avg 2.09
AvgDlyVol 140,336.87 3MthChg 0.17 (8.50%)
6MthChg -0.23 (-9.58%) 12MthChg -0.28 (-11.43%)
Div. Yield 9.2165 Risk Factor 0.003861024
Sector Pharmaceuticals
Company Profile
May & Baker Nigeria Plc engages in the manufacture, sale, and distribution of human pharmaceuticals and vaccines, and food and beverage products in Nigeria. Its product line includes cough and cold preparations, anti histamines, sulphonamides, anti-amoebicides, anti-malarials, anti-dibiaetics, analgesics, anti-hypertensives, and antibiotics. The company also offers noodles under the Mimee brand name; and water under the Lily brand name. May & Baker Nigeria Plc was founded in 1944 and is headquartered in Lagos, Nigeria.

Website:	www.may-baker.com
Founded in:	1944

Statement of Comprehensive Income as at

Name Amount
Revenue 9,352,636.00
Profit before tax 605,622.00
Taxation -234,756.00
Profit after tax 370,866.00
Transfer to revenue reserve 370,866.00
Profit attributable to:
Owners of the company 370,866.00
Non-controlling interest
Earnings per 50k Share 37.84
Net assets per 50k Share 3.39
Name Title
Theophilus Danjuma Non-Executive Chairman
Nnamdi Okafor Managing Director/Chief Executive Officer, Executive Director
Ayodeji Aboderin Financial Controller/Chief Financial Officer
Ezekiel Ibidapo Pharmaceutical Manufacturing Operations, Executive Director
Valentine Okelu General Manager/Head, Foods Division
Chukutem Chukuka Head, Pharma Sales and Marketing
Gladys Umoh Head, Human Capital Development
Edudie Abebe Non-Executive Director
Adebayo Adeleke Non-Executive Director
Ishaya Dankaro Non-Executive Director
Gloria Odumodu Non-Executive Director